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Abstract Orexins A and B are peptides produced mainly by
hypothalamic neurons that project to numerous brain struc-
tures. We have previously demonstrated that rat cortical neu-
rons express both types of orexin receptors, and their activa-
tion by orexins initiates different intracellular signals. The
present study aimed to determine the effect of orexins on the
Akt kinase activation in the rat neuronal cultures and the
significance of that response in neurons subjected to hypoxic
stress. We report the first evidence that orexins A and B
stimulated Akt in cortical neurons in a concentration-
and time-dependent manner. Orexin B more potently
than orexin A increased Akt phosphorylation, but the
maximal effect of both peptides on the kinase activation
was very similar. Next, cultured cortical neurons were
challenged with cobalt chloride, an inducer of reactive
oxygen species and hypoxia-mediated signaling path-
ways. Under conditions of chemical hypoxia, orexins
potently increased neuronal viability and protected cor-
tical neurons against oxidative stress. Our results also
indicate that Akt kinase plays an important role in the pro-
survival effects of orexins in neurons, which implies a possi-
ble mechanism of the orexin-induced neuroprotection.
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Orexins are neuropeptides discovered simultaneously in 1998
by two independent research groups, one of which named
them orexins (A and B) and the other hypocretins
(hypocretin-1 and hypocretin-2) (de Lecea et al. 1998;
Sakurai et al. 1998). Orexins A (33 amino acids) and B (28
amino acids) are proteolytically processed from a common
precursor peptide, preproorexin (Alvarez and Sutcliffe 2002).
Both neuropeptides interact with G protein-coupled receptors,
types 1 (OX1R) and 2 orexin receptor (OX2R), which display
different affinity for orexins (Voisin et al. 2003). On the basis
of binding and Ca2+ elevation studies in recombinant expres-
sion systems, it has been established that orexin A couples to
OX1R with a 5- to 100-fold higher affinity than orexin B,
whereas both peptides have similar affinities to OX2R
(Ammoun et al. 2003; Sakurai et al. 1998). OXRs are widely
distributed in the central nervous system and peripheral tis-
sues. Interestingly, orexin-containing neuronal cell bodies,
although localized only in lateral hypothalamic area and near-
by regions, project to numerous brain structures and are reg-
ulated by many neurotransmitter systems (Kukkonen et al.
2002; Kukkonen 2012; Nambu et al. 1999; Peyron et al.
1998). This anatomical architecture of orexin neurons and
the wide distribution of orexin receptors appear to be essential
for multiple functions of these neuropeptides. Orexins were
originally described to play a key role in the control of feeding
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and sleep–wake cycle, with an emphasis on their contribution
to the pathogenesis of narcolepsy, but since their discovery
many other physiological functions of the peptides have been
well-documented, i.e., regulation of motivated behaviors,
such as arousal, reward-seeking and drug addiction, metabolic
rate and thermogenesis, autonomic or endocrine processes
(Aston-Jones et al. 2010; Berthoud et al. 2005; Chemelli
et al. 1999; Mieda et al. 2004; Randeva et al. 2001; Sakurai
et al. 1998; Spinazzi et al. 2006; Thompson and Borgland
2011; Zhang et al. 2009). Multitude of physiological actions
controlled by orexins originates from highly diverse cellular
responses to the orexin receptors stimulation. It has been
demonstrated that stimulation of orexin receptors may trigger
activation of classical phospholipase C (PLC) cascade (PLC-
IP3/DAG) with a subsequent robust increase in intracellular
Ca2+ concentration in recombinant cell lines and native sys-
tems (Johansson et al. 2007; Lund et al. 2000;Mazzocchi et al.
2001; Randeva et al. 2001). Other orexin-activated signaling
pathways include adenylyl cyclase (AC)/cyclic AMP, phos-
pholipase D/phosphatidic acid (PA), phospholipase A2/arachi-
donic acid release and mitogen-activated protein kinase
(MAPK)/stress-activated protein kinase (Holmqvist et al.
2005; Magga et al. 2006; Tang et al. 2008; Urbańska et al.
2012; Woldan-Tambor et al. 2011; Zhu et al. 2003). Despite a
large number of orexins-mediated signaling pathways de-
scribed in the literature, a role of these neuropeptides in
activation of Akt kinase is at present largely unknown.
Therefore, the aim of our work was to study the effect of
orexins on the Akt kinase activation in primary neuronal cell
cultures.
It has been demonstrated that, depending on the activated
signal cascade, orexins can affect different cellular processes,
such as neuronal excitation, cell growth, plasticity, death or
survival (Ammoun et al. 2006; Holmqvist et al. 2005;
Kukkonen 2012; Ramanjaneya et al. 2009; Rouet-Benzineb
et al. 2004; Tang et al. 2008). Recent studies in a model of
cerebral ischemia in rats indicated a new role of orexin A as a
neuroprotective factor. The peptide was shown to attenuate
ischemia–reperfusion injury by reducing the number of apo-
ptotic cells (Kitamura et al. 2010; Yuan et al. 2011). As
ischemia is a restriction in blood supply to the tissue, causing
a shortage of oxygen and glucose needed for cellular metab-
olism, in the present study we also tested neuroprotective
potential of both orexins in neuronal cultures derived from
rat cerebral cortex subjected to hypoxic stress induced by
cobalt chloride. Cobaltous ions mimic hypoxia condi-
tions by activation of hypoxia-mediated signaling path-
ways and generation of reactive oxygen species (ROS)
(Chandel et al. 1998; Vengellur and LaPres 2004).
Finally, as Akt kinase is well known for its ability to control
cellular survival and apoptosis, we checked whether this ki-
nase is involved in neuroprotective effects of orexins in cells
subjected to chemical hypoxia.
Materials and Methods
Animals and Neuronal Cell Culture
Experiments were performed on primary neuronal cell cul-
tures prepared fromWistar rat embryos on day 17 of gestation.
Animal procedures were in a strict accordance with the Polish
governmental regulations concerning experiments on an-
imals (Dz.U.05.33.289), and the experimental protocol
was approved by the Local Ethical Commission for
Experimentation on Animals.
Primary neuronal cell cultures were prepared according to
the method of Brewer (1995), as previously described in detail
(Nowak et al. 2007; Urbańska et al. 2012). Briefly, the rat
cerebral cortex was isolated from fetal brain, incubated for
15 min in trypsin/EDTA (0.05 %) at 37 °C followed with a
trituration in a solution of DNase I (0.05 mg/ml) and fetal
bovine serum (20 %) in Ca2+- and Mg2+-free PBS. The cells
were maintained in Neurobasal medium supplemented with
B27 (2%), 2 mM glutamine, 100 U/ml penicillin, and 100 μg/
ml streptomycin. Seventy-two hours after plating, the cellular
proliferation was stopped by adding to the medium the solu-
tion of 1-β-D-arabinofuranosylcytosine (5 μM). The glial
content in neuronal cultures, analyzed by using antibody
against glial fibrillary acidic protein, was estimated to be 6–
10 % of the total cell population (Urbańska et al. 2012). Cells
were cultured as monolayer on poly-L -ornithine coated
multi-well plates or 60 mm culture dishes for 7–8 days
before experiments at 37 °C in a humidified atmosphere
with 5 % CO2.
Protein Extraction and Western Blot Analysis
Whole cell extracts were prepared from neuronal cultures treat-
ed with orexins to activate Akt. Briefly, following treatments
cells were washed in ice-cold PBS and removed from the
surface by scraping in cell lysis buffer (M-PER Mammalian
Protein Extraction Reagent, Thermo Scientific, Rockford, IL,
USA) with protease and phosphatase inhibitors (Halt Protease
and Phosphatase Inhibitor Cocktail, Thermo Scientific,
Rockford, IL, USA) according to the manufacturer’s instruc-
tions. Cell extracts were collected and stored at −70 °C until
protein concentration was measured by the Pierce BCA Protein
Assay Kit (Thermo Scientific, Rockford, IL, USA).
Electrophoresis and blotting was performed using NuPAge
Novex system with the XCell SureLock Mini-Cell and the
Novex Semi-Dry Blotter (Invitrogen, Paisley, UK) according
to the manufacturer’s instruction. Denatured samples with an
equal amount of protein per lane (20 μg) were separated on
gradient gels (4–12 % Bis-Tris gel), electrotransferred on nitro-
cellulose membrane (Hybond C extra, Amersham Biosciences,
Buckinghamshire, UK) and blocked in 5% (w /v) bovine serum
albumin in TBST (0.1 % Tween-20 in Tris Buffered Saline,
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TBS), for 1 h at room temperature. After 4 °C overnight
incubation with primary antibodies (phosphoSer473-Akt, 1:1,
000, Cell Signaling Technology, Danvers, MA, USA) mem-
branes were washed several times in TBST, and then incubated
in TBST-milk with horse radish peroxidase-conjugated second-
ary antibodies (anti-rabbit IgG, 1:2,000, Dako, Glostrup,
Denmark) for 1 h at room temperature. Peroxidase enzymatic
activity was detected using Super Signal West Pico
Chemiluminescent Substrate (Thermo Scientific, Rockford,
IL, USA) and visualized on G-box iChemi XT4 system utiliz-
ing GeneSys automatic control software (Syngene, Cambridge,
UK). Then, membranes were stripped in Restore Western Blot
Stripping Buffer (Thermo Scientific, Rockford, IL, USA) for
10 min at room temperature and after extensive washing
reprobed with total Akt antibody (1:1,000, Cell Signaling
Technology, Danvers, MA, USA). The same secondary anti-
body and detection system was used as described above. The
phospho-specific signal was correlated to the total Akt.
Cell Viability Assay
Cell viability and mitochondrial function were measured by
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H -tetrazolium
bromide (MTT) reduction to MTT formazan by cellular mi-
tochondrial dehydrogenases. Following exposure to orexin A,
orexin B, and cobalt chloride, neuronal cells were washed in
PBS before the addition of MTT (0.5 mg/ml) and incubated
for 3 h at 37 °C. Formazan crystals were solubilized in
dimethyl sulfoxide (100 %) and absorbance, proportional to
the number of viable cells, was measured at 570 nm using a
microplate reader (EnVision 2103, Perkin Elmer, Turku,
Finland).
Reduced-MitoTracker Orange Staining
We monitored oxidative stress in rat neuronal cultures by utiliz-
ing a dye that is internalized within cells and does not fluoresce
until its reducedmoieties are oxidized.MitoTracker Orange CM-
H2TMRos (Invitrogen, Paisley, UK) was successfully used to
study ROS generation in neurons (Ibarretxe et al. 2006; Kweon
et al. 2001; Lampe et al. 2010). After 24-h incubation of rat
neuronal cultures with orexins A and B in the presence or
absence of cobalt chloride (100 μM), culture medium was
removed and the cells were stained with CM-H2TMRos accord-
ing to the manufacturer’s instruction. Finally, the cells were
washed with PBS, counterstained with 2 μg/ml Hoechst 33342
for 20 min, and subjected for analysis by high content reader
ArrayScan VTI HCS Reader (Thermo Scientific, Rockford, IL,
USA) equipped with ×10 objective. Routinely, images of 20
fields/well were acquired and 5000 cells/well were analyzedwith
Cell Health Profiling Bioapplication V3 software (Cellomics
BioApplications, Cellomics, Thermo Scientific, Rockford, IL,
USA). Oxidative stress level in rat cortical neurons was
calculated on the basis of mean cellular fluorescence and
expressed as a percentage of the respective control.
Chemicals
Orexins A and B were from NeoMPS (Strasbourg, France).
Poly-L -ornithine, DNase I, trypsin, glutamine, penicillin,
streptomycin, 1-β-D-arabinofuranosylcytosine, 3-(4,5-di-
methyl-2-thiazolyl)-2,5-diphenyl-2H -tetrazolium bromide
(MTT), dimethyl sulfoxide, cobalt chloride, TBS, Tween 20,
albumin from bovine serum, non-fat dried bovine milk were




4-yl]-2-methyl-3-butyn-2-ol) were from Tocris Bioscience
(Bristol, UK). Neurobasal medium, B27, fetal bovine serum,
CM-H2TMRos, NuPAGE MES SDS Running Buffer,
NuPAGE Transfer Buffer were from Invitrogen (Paisley, UK).
Data Analysis
Data are expressed as mean±standard error of the mean
(SEM) values and were analyzed for statistical significance
by one-way ANOVA followed by post hoc Student–
Newman–Keul’s test, using GraphPad Prism 5 (GraphPad,
San Diego, CA, USA).
Results
Orexins Stimulate the Akt kinase Activity in Rat Cortical
Neurons
Orexins A and B evoked phosphorylation of Akt kinase in
cultured rat cortical neurons. The kinetics of Akt activation by
orexins was analyzed by Western blot, using an antibody that
detects endogenous levels of Akt when phosphorylated
(activated) at Ser473. Under resting conditions the activity of
Akt in neuronal cells was very low, but upon stimulation of the
cells with 0.1 μM orexins A and B it increased significantly
(Fig. 1, top). The maximal phosphorylation of Akt (approxi-
mately 500% above the control values) was observed after 1 h
of stimulation by orexins and decreased toward a plateau
between 6–24 h. After 24 h stimulation of cortical neurons
with orexins, the phospho-Akt immunoreactivity still
remained higher than the basal level (114 and 76 % above
control for orexins A and B, respectively) (Fig. 1, bottom).
The profile of action of both peptides was very similar (Fig. 1,
bottom).
A dose-dependence study showed that orexins, incubated
with neuronal cells for 1 h, were able to activate Akt kinase at
all concentrations tested (0.0001–1 μM ) (Fig. 2). Interestingly,
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orexin B more potently (EC50=1.8 nM) than orexin A (EC50=7
nM) stimulated Akt phosphorylation but, as described above,
the maximal effect of both peptides on the Akt activation was
very similar (Fig. 2, bottom).
Orexins Protect Neurons from the Cobalt Chloride-Induced
Toxicity
Cultured cortical neurons were challenged with 100 μM
cobalt chloride and cell viability and mitochondrial func-
tion were measured by MTT test. Incubation of cortical
neurons with cobalt chloride for 48 h resulted in a potent,
about 50 %, reduction of cell viability as compared with
control values (taken as 100 %). Parallel incubation of
neurons with orexins (0.0001–1 μM) attenuated the toxic
effect of cobalt chloride (Fig. 3). Under conditions of
chemical hypoxia, orexin A induced a statistically signif-
icant (at 0.01–1 μM concentration range) increase of
neuronal cell viability, with the highest response, up to
71 % of control values, observed at 0.1 μM (Fig. 3, top).
Orexin B more potently than orexin A enhanced cell
viability by 80 % of control values at 0.01 μM and
protected neurons at a wider range of concentrations
(0.0001–1 μM) (Fig. 3, bottom).
Fig. 1 Effects of orexins A
and B on the Akt activation in
primary neuronal cultures from
rat cerebral cortex. Cells were
incubated with the peptides
(0.1 μM) for the indicated time
periods and analyzed by
immunoblot against pAkt (Ser473).
Top panel shows results of
representative experiments. Data
are presented as mean±SEM of
4–7 values per group and




*P <0.05; ***P <0.001
Fig. 2 Concentration-dependent
effects of orexins A and B on the
Akt activation in primary rat
neuronal cultures. Cells were
incubated with the peptides
(0.0001–1 μM) for 1 h and
analyzed by immunoblot against
pAkt (Ser473). Top , results of
representative experiments. Data
are presented as mean±SEM of
4–7 values per group and




*P <0.05; ***P <0.001
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Orexins Protect Cortical Neurons from the Cobalt
Chloride-Induced Oxidative Stress
Mitochondria act as O2 sensors by increasing the genera-
tion of ROS during hypoxia, and cobalt chloride mimics
this response by inducing ROS generation (Chandel et al.
1998; Stenger et al. 2011). To confirm that orexins protect
cortical neurons from the cobalt chloride toxicity, we mea-
sured oxidative stress level in rat cortical neurons using
CM-H2TMRos, a ROS-sensitive probe, in the presence or
absence of cobalt chloride (100 μM), treated with orexins
at concentrations at which we observed the highest peptides
responses, i.e., 0.1 μM for orexin A and 0.01 μM for
orexin B. Both peptides diminished the cobalt chloride-
induced ROS generation to the basal level. In the absence
of cobalt chloride, orexins did not alter cellular oxidative
stress status (Fig. 4).
Akt Kinase Is Involved in Neuroprotection by Orexins
Against the Cobalt Chloride Toxicity
To test whether activation of Akt kinase is involved in the
neuroprotective effect of orexins, we measured neuronal via-
bility in the presence of Akt kinase inhibitors, 10-DEBC
hydrochloride (2.5 μM) and GSK690693 (1 μM). Control
experiments performed in the absence of orexins revealed that
these Akt inhibitors had no effect on the cobalt chloride
toxicity in cortical neurons. When orexins were added togeth-
er with Akt inhibitors to cortical neurons cultured under
hypoxic conditions, the neuroprotective effect of peptides
was completely abolished (Fig. 5). To test possible toxic
effects of these inhibitors, neuronal cell cultures were treated
with 10-DEBC hydrochloride and GSK690693, at concentra-
tions used in experiments, and no toxicity was observed (data
not shown).
Discussion
In the present work, we focused on the effect of orexins onAkt
kinase stimulation in primary rat neuronal cultures and the
significance of the orexin-induced Akt activation in
neurons subjected to hypoxic stress. We have previously
demonstrated that rat cortical neurons express both types
of orexin receptors and their activation by orexins initi-
ated different signaling pathways (Urbańska et al. 2012;
Zawilska et al. 2013).
Despite of many literature reports indicating an ability of
orexins to activate various intracellular signals, there are only
a few findings demonstrating the effect of orexins on the Akt
Fig. 3 Protective effects of orexins A and B in rat neuronal cultures
challenged with cobalt chloride (100 μM). Cells were incubated with the
peptides (0.0001–1 μM) in parallel with cobalt chloride for 48 h and cell
viability was analyzed byMTT test. Data are mean±SEM of 6–24 values
per group and expressed as a percentage of the respective control. Aster-
isks indicate statistically significant difference from cobalt chloride; *P <
0.05; **P <0.01; ***P<0.001
Fig. 4 Effects of orexins A and B on oxidative stress level in neuronal
cultures from rat cerebral cortex. Neurons were treated with orexins A
(0.1 μM) and B (0.01 μM) for 24 h in the presence or absence of cobalt
chloride (100 μM) and stained with CM-H2TMRos. Data are mean±
SEM of 5–12 replicates per group and expressed as a percentage of the
respective control. Asterisks indicate statistically significant difference
from control; **P<0.01
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signaling. For example, orexin A was shown to inhibit
proglucagon gene expression through activation of Akt kinase
in clonal pancreatic A cells (Göncz et al. 2007) and stimulated
glucose uptake in pr imary ra t ad ipocytes in a
phosphatidylinositide 3-kinase-dependent manner (Skrzypski
et al. 2011). The results obtained in the present study provide
the first evidence that orexins A and B were able to potently
induce Akt phosphorylation in rat primary cortical neurons.
Both peptides acted at the wide range of concentrations and
the calculated EC50 values were in low nanomolar range (∼2–
7 nM), suggesting that the Akt stimulation is of physiological
relevance. The orexins-mediated Akt response was rather
slow as there was no statistically significant increase of Akt
activity during the first 15 min of incubation. The most
pronounced response was observed after one hour of incuba-
tion with the peptides. Interestingly, elevated phospho-Akt
immunoreactivity was also observed after 24 h, suggesting
an involvement of Akt signaling in long-term cellular effects.
In different types of neuronal cells, the Akt signaling plays
a crucial role in mediating survival signals (Brunet et al.
2001). This kinase also plays an important role in
neurogenesis, axon establishment, and elongation (Diez
et al. 2012). Altered Akt function has been associated to many
pathologies, such as Alzheimer’s disease (Liao and Xu 2009),
Huntington disease (Warby et al. 2009; Zala et al. 2008),
schizophrenia (Emamian et al. 2004), spinocerebellar ataxia
type I (Chen et al. 2003), or autism (Kwon et al. 2006). Studies
performed on recombinant cell lines have shown that orexins
are capable of inducing both death- and survival-promoting
signaling through activation of the classical MAPK pathways
(Ammoun et al. 2006; Tang et al. 2008). The essential role of
Akt signaling in neuronal survival and development prompted
us to check whether this kinase mediates the orexin-initiated
survival of cortical neurons against the cobalt-induced hypox-
ic toxicity. According to the literature, exposure to cobalt
promotes a response similar to hypoxia by activating
hypoxia-mediated signaling pathways aberrantly under
normoxia and potently augmenting ROS generation in mito-
chondria (Chandel et al. 1998; Vengellur and LaPres 2004).
Prolonged chemical hypoxia can also induce genes involved
in cell death (Vengellur and LaPres 2004). In our study, we
observed about 50 % reduction of neuronal cells survival after
48-h incubation with cobalt chloride at 100 μM. Orexins,
added to hypoxic neuronal cultures, potently attenuated cobalt
toxicity. In this context, it is worth to note that our previous
findings in cortical neurons cultures showed the stimulatory
effect of orexins A and B on neuronal survival under
normoxia with a parallel attenuation of caspase-3 activity,
indicating a new role of orexins as potential neuroprotective
factors (Sokołowska et al. 2012). Recently, Butterick et al.
(2012) have demonstrated that orexins protected immortalized
hypothalamic neurons against H2O2-induced toxicity by de-
creasing lipid peroxidative stress and caspase-dependent apo-
ptosis. In the light of these findings orexins seem to be
neuroprotective against oxidative stress by modulation of
anti-apoptotic mechanisms. Although the knowledge of the
orexin-evoked neuroprotection is evolving, there are still
many questions concerning factors mediating neuronal sur-
vival. Results from the present study point at an important role
of Akt as one of the possible mediators of the pro-survival
effects of orexins in neurons. Two Akt inhibitors, 10-DEBC
hydrochloride and GSK690693, entirely suppressed the
orexins A- and B-induced protection of cortical neurons from
cobalt toxicity. Thus, the role of Akt in this process seems to
be undeniable.
The question remains how the orexin-activated Akt in-
duces the anti-apoptotic machinery. A series of studies with
Fig. 5 Effects of Akt kinase inhibitors, 10-DEBC hydrochloride
(2.5 μM) and GSK690693 (1 μM), on orexins A- (0.1 μM) and B-
stimulated (0.01 μM) cell viability in rat neuronal cultures challenged
with cobalt chloride (100 μM). Data are mean±SEM of 6–19 values per
group and expressed as a percentage of the respective control. Asterisks
indicate statistically significant difference from orexins A and B, respec-
tively; **P<0.01; ***P<0.001
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the use of survival factors have demonstrated that Akt directly
phosphorylates a major class of transcription factors—the
Forkhead box transcription factor, class O and inhibits their
ability to induce the expression of death genes (Brunet et al.
1999). Akt was also reported to promote cell survival by
inhibiting the activity of p53 or inducing the expression of
survival genes by activating two transcription factors, cAMP-
responsive element binding protein, and nuclear factor κB (Du
and Montminy 1998; Ozes et al. 1999; Yamaguchi et al.
2001). In addition to its effects on transcription, Akt phos-
phorylates BAD (Bcl-2 family member) inhibiting BAD pro-
apoptotic functions (Datta et al. 1997). It is also suggested that
Akt may promote survival indirectly by affecting cellular
metabolism. In particular, Akt prevents the depletion of me-
tabolites by increasing ATP or glucose levels (Brunet et al.
2001). Thus, it seems possible that orexins, the well-known
factors influencing metabolism, arousal, and energy expendi-
ture, may regulate energy balance towards cell survival with
the Akt contribution to this process. Understanding the mo-
lecular mechanisms of orexin-promoted neuroprotection
could be addressed in future studies to design new therapies
of brain pathologies.
In summary, we demonstrated the first evidence that both
orexins A and B potently stimulated Akt activation in primary
neuronal cultures from rat cerebral cortex. We also showed
that orexins protected cortical neurons against cobalt-induced
oxidative stress and pointed at the important role of Akt as the
mediator of pro-survival effects of orexins in neurons.
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